MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Hyposmia is Associated with Positive CSF α-Synuclein Seeding in Normal Pressure Hydrocephalus

    S. Weber, C. Farris, Y. Ma, M. Dakna, M. Starke, C. Trenkwalder, L. Concha-Marambio, B. Mollenhauer (Goettingen, Germany)

    Objective: To detect α-synuclein (αSyn) pathology and associated clinical characteristics in patients with idiopathic normal pressure hydrocephalus (iNPH) through cerebrospinal fluid (CSF) αSyn seed amplification…
  • 2024 International Congress

    Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy

    HJ. Kim, HJ. Ha, CY. Lee, JY. Yun (Seoul, Republic of Korea)

    Objective: Introduction: Leukodystrophies are primarily known as childhood diseases, but recent advances in genetic testing and brain imaging have led to an increase in reports…
  • 2024 International Congress

    Clinical and neuroimaging factors associated with survival in Multiple System Atrophy

    G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)

    Objective: To assess clinical and neuroimaging factors associated with survival in a cohort of patients with a final clinical diagnosis of Multiple System Atrophy (MSA)…
  • 2024 International Congress

    Optical Coherence Tomography Findings in Multiple System Atrophy: Insights into Disease Subtypes, Clinical Correlations, and Dopaminergic Degeneration

    Y. Kang (Hangzhou, China)

    Objective: This study aimed to evaluate optical coherence tomography (OCT) findings in multiple system atrophy (MSA) patients, with a focus on disease subtypes, clinical correlations,…
  • 2024 International Congress

    Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study

    XY. Li, G. Tang, FT. Liu, J. Wang (Shanghai, China)

    Objective: Based on a relatively large cohort, we aimed to show the switch of cognitive status in patients with progressive supranuclear palsy (PSP) after one-year follow-up…
  • 2024 International Congress

    Cholinergic denervation is more severe in patients with Parkinson disease compared to Progressive Supranuclear Palsy-Parkinsonism subtype: A [18F]-FEOBV PET study

    P. Kanel, G. Carli, J. Barr, T. Brown, S. Roytman, K. Frey, P. Scott, R. Koeppe, R. Albin, N. Bohnen (Ann Arbor, USA)

    Objective: : To investigate cholinergic brain regional differences between Progressive supranuclear palsy with parkinsonism (PSP-P) and Parkinson's disease (PD), using the highly selective radiotracer for…
  • 2024 International Congress

    Validation of Inertial Monitoring Units for Gait Assessment in Progressive Supranuclear Palsy

    A. Blazek, C. Hogen, J. Whitwell, K. Josephs, K. Kaufman, F. Ali (Rochester, USA)

    Objective: To evaluate the validity and precision of using inertial measurement units (IMU) for measurement of kinematics and spatial-temporal features of gait in progressive supranuclear…
  • 2024 International Congress

    Salivary and Plasma Heme Oxygenase-1 Concentration as a New Potential Biomarker in Parkinson Disease

    R. Yadav (Kathmandu, Nepal)

    Objective: The objective was to assess the utility of plasma and salivary heme oxygenase-1 (HO-1) concentration as a new potential biomarker for the diagnosis of…
  • 2024 International Congress

    Visual Hallucinations and α-Synuclein Oligomers in Dementia with Lewy Bodies (DLB)

    L. Franke, H. Sekiya, T. Ferman, P. Mclean, D. Dickson (Jacksonville, USA)

    Objective: To determine whether visual hallucinations (VH) in dementia with Lewy bodies (DLB) are associated with α-synuclein oligomers. Background: It is not known whether VH…
  • 2024 International Congress

    Association between Kinetic Parameters of Alpha-synuclein Seed Amplification Assay in CSF and Parkinson’s Disease Subtypes.

    P. Grillo, G. Riboldi, A. Pisani, L. Concha, U. Kang (New York City, USA)

    Objective: To assess differences in kinetics parameters of the αSyn seeding amplification assays in CSF (CSF-αSyn-SAA) in Parkinson’s Disease (PD) subtypes based on the presence…
  • « Previous Page
  • 1
  • …
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley